From Tuberculosis Bedside to Bench: the Potential of RPS20, KIF13B and UBE2B Splicing As Biomarkers and the Regulatory Mechanism of UBE2B Splicing

Mengyuan Lyu,Jian Zhou,Yanbing Zhou,Weelic Chong,Wei Xu,Hongli Lai,Lu Niu,Yang Hai,Xiaojun Yao,Sheng Gong,Qinglan Wang,Yi Chen,Yili Wang,Chengdi Wang,Liyu Chen,Zewang Gema,Jiongjiong Zeng,Binwu Ying
DOI: https://doi.org/10.2139/ssrn.4276367
2022-01-01
Abstract:Background: Alternative splicing (AS) observes changes in transcript expression, the proportion among different transcripts, and even protein function, conferring its ability to capture disease related-tiny signals and ensuring its sensitivity and specificity as biomarkers. Tuberculosis (TB)-specific AS biomarkers are rarely reported. We aimed to depict an AS landscape, identify promising AS biomarkers and investigate the regulatory mechanism of the AS biomarker in TB.Methods: The discovery and validation cohorts (2,284 participants) were prospectively enrolled for developing biomarkers. TB-progression and treatment cohorts (1,553 samples) were constructed to clarify biomarker application scopes. Regulatory mechanism was explored in heat-killed mycobacterium tuberculosis (HKMT) stimulated macrophages.Findings: Altogether 605 differentially splicing events between the TB and control groups were preliminary found. S100A8-intron1-retention intron (RI), RPS20-exon1-alternaitve promoter (AP), KIF13B-exon4-skipping exon (SE), and UBE2B-exon7-SE were selected. The splicing of the latter three remained remarkably different in the validation cohort (P<0·001), but not in TB-progression and treatment cohorts. Subgroup analysis indicated that UBE2B-exon7-SE splicing was not affected by confounding factors. The excellent performance of classifiers verified the diagnostic value of these events (area under curve>0·9). HKMT stimulation inhibited UBE2B-exon7-SE splicing (P<0·05) and SRSF1 expression (P<0·001). Compared with IgG group, IP group was more enriched in UBE2B sequence (P<0·05), indicating the SRSF1-UBE2B sequence interaction. HKMT-stimulated OE-SRSF1 macrophages promoted UBE2B-exon7-SE splicingcompared to OE-vector ones, while SRSF1 knockdown induced the opposite effect.Interpretation: RPS20-exon1-AP, KIF13B-exon4-SE, and UBE2B-exon7-SE were regarded as promising biomarkers for TB diagnosis, but not for TB progression and prognosis. MTB may mechanically inhibit UBE2B-exon7-SE via arresting SRSF1.Trial Registration Details: (Registration number of Chinese Clinical Trial Registry: ChiCTR1900028670).Funding Information: This work was funded by the National Science & Technology Pillar Program during the 13th Five-year Plan Period [2018ZX10715003] and National Natural Science Foundation of China [82272416].Declaration of Interests: The authors declare no conflicts of interest.Ethics Approval Statement: Biomedical Ethics Committee of West China Hospital, Sichuan University approved this study. All participants provided informed consent.
What problem does this paper attempt to address?